Company Overview and News

4
Podcast | Trade war fears grips equity markets across the globe; Nifty ends below 10,950

2018-07-11 moneycontrol
Bucking the global trend, Nifty managed to close in positive compared to muted performance seen in other Asian markets amid fears of trade wars between US and China.
BAJAJ-AUTO 532959 IDBI 532977 TTNQY 533278 532215 500470 532540 AXISBANK 500570 TATAMOTORS CLNDY V2RETAIL 500116 AXB IBN 532867 AXBKY AXBA ICICIBANK GAMMNINFRA TTST TATASTEEL TATLY 532174 TCS COALINDIA TTM

4
An evening walk down Dalal Street: Trade war fears grips equity markets across the globe; Nifty ends below 10,950

2018-07-11 moneycontrol
Bucking the global trend, Nifty managed to close in positive compared to muted performance seen in other Asian markets amid fears of trade wars between US and China.
BAJAJ-AUTO 532959 IDBI 532977 TTNQY 533278 532215 500470 532540 AXISBANK 500570 TATAMOTORS CLNDY V2RETAIL 500116 AXB IBN 532867 AXBKY AXBA ICICIBANK GAMMNINFRA TTST TATASTEEL TATLY 532174 TCS COALINDIA TTM

0
Gammon Infra locked at 5% lower circuit on termination of concession pact with APRDC

2018-07-11 moneycontrol
Shares of Gammon Infrastructure Projects has locked at 5 percent lower circuit on termination of contract with APRDC.
UBNC GAMMNINFRA 532959

0
Gammon Infrastructure Projects Limited - Updates

2018-07-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GAMMNINFRA 532959

11
Brookfield to sharpen focus on renewable energy sector in India

2018-06-28 livemint
Mumbai: Canada-based Brookfield Asset Management Inc. is looking to increase its focus on renewable energy in India, said two people aware of the firm’s plans, on the condition of anonymity. The asset manager has so far been focussing largely on the real estate and roads segment.
GAMMNINFRA MIC 532959 GLBL BEP

0
Gammon Infrastructure Projects Limited - Financial Result Updates

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GAMMNINFRA 532959

0
Gammon Infrastructure Projects Limited - Change in Director(s)

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GAMMNINFRA 532959

9
Podcast | Sensex recovers 150 points off lows, Nifty above 10,700; banks fall

2018-05-16 moneycontrol
Equity benchmarks witnessed a volatile day of trade on Tuesday as confused investors looked for cues from Karnataka on the domestic side, while developments from Korea dominated the global cues.
HINDALCO IBN 532959 532712 532832 HNDNF SYNDIBANK ICICIBANK GAMMNINFRA 532276 PNJZY RCOM 532461 532174 PNB 500440 IBREALEST

23
RIL, ICICI Bank, HDFC twin drag Sensex 156 pts; Midcap index outperforms, HUL top gainer

2018-05-16 moneycontrol
The market ended volatile session lower on Wednesday, but recovered half of its losses amid continued uncertainty over the formation of government in Karnataka. Recovery in rupee post RBI's likely intervention and fall in crude oil prices also supported the market.
500325 532959 RELIANCE KTKBANK 532538 532712 BHRQY 532832 SYNDIBANK GRANULES 532660 RCOM 532461 532482 VIVIMEDLAB RIGD UCLQY HDFCBANK BHARTIARTL RLNIY SBAZ HINDALCO IBN UCLQF ULTRACEMCO HNDNF 532454 532652 ICICIBANK GAMMNINFRA 532276 PNJZY HDB 532174 500180 PNB 500440 IBREALEST

15
Market Live: Sensex dips 100 pts; FMCG index jumps on HUL, ITC support

2018-05-16 moneycontrol
Century Plyboards Q4 results: The company has reported 35 percent decline in its Q4 net profit at Rs 36 crore, while revenue was up 11.4 percent at Rs 544.1 crore.
AIAENG 500325 532959 RELIANCE 532538 532712 GLKQY 532343 532683 GRANULES 532660 RCOM 532461 532482 CENTURYPLY VIVIMEDLAB RIGD UCLQY RLNIY GLENMARK HINDALCO TVSMOTOR JYOTHYLAB IBN 532926 UCLQF 532548 ULTRACEMCO HNDNF ICICIBANK GAMMNINFRA PNJZY 532296 532174 PNB 500440 AAGGY

15
Market Live: Sensex trims losses on recovery in banks; rupee gains 27 paise after hitting 68.13/$

2018-05-16 moneycontrol
Earnings: Two-wheeler maker TVS Motor Company has reported a healthy growth of 30.6 percent year-on-year in profit at Rs 165.6 crore fro the quarter ended March 2018, but overall earnings barring revenue missed analyst expectations.
AIAENG 500325 532959 RELIANCE 532538 532712 GLKQY SYNDIBANK 532343 532683 GRANULES 532660 RCOM 532482 VIVIMEDLAB RIGD UCLQY RLNIY GLENMARK TVSMOTOR IBN UCLQF ULTRACEMCO ICICIBANK GAMMNINFRA 532276 532296 532174 AAGGY

7
Gammon Infra jumps 18% as ICICI Bank acquires nearly 18% stake in Co

2018-05-16 moneycontrol
Share price of Gammon Infrastructure Projects advanced 18.3 percent intraday Wednesday as private lender ICICI Bank acquired nearly 18 percent stake in the company through invocation of pledged shares.
ICICIBANK GAMMNINFRA 532174 IBN 532959

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...